1. Home
  2. CTM vs HRTX Comparison

CTM vs HRTX Comparison

Compare CTM & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

SELL

Current Price

$0.58

Market Cap

63.1M

Sector

Technology

ML Signal

SELL

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

SELL

Current Price

$0.36

Market Cap

61.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CTM
HRTX
Founded
2019
1983
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
61.2M
IPO Year
2022
2007

Fundamental Metrics

Financial Performance
Metric
CTM
HRTX
Price
$0.58
$0.36
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
376.6K
★ 2.4M
Earning Date
11-06-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
N/A
EPS
★ N/A
N/A
Revenue
$52,866,001.00
★ $154,904,000.00
Revenue This Year
$6.00
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.10
7.36
52 Week Low
$0.48
$0.26
52 Week High
$1.36
$1.58

Technical Indicators

Market Signals
Indicator
CTM
HRTX
Relative Strength Index (RSI) 36.81 51.30
Support Level $0.56 $0.29
Resistance Level $0.65 $0.46
Average True Range (ATR) 0.02 0.04
MACD -0.01 0.00
Stochastic Oscillator 8.28 52.02

Price Performance

Historical Comparison
CTM
HRTX

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: